Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

393 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Rapid Cytologic Double Staining of Epstein-Barr Virus-encoded Small RNA and Cell Surface Markers for Diagnosis of Epstein-Barr Virus-associated Hemophagocytic Lymphohistiocytosis.
Takahashi N, Kudo K, Tanaka M, Kumagai N, Sato T, Kamio T, Sasaki S, Terui K, Kurose A, Yanagisawa R, Nakazawa Y, Ito E. Takahashi N, et al. Among authors: yanagisawa r. J Pediatr Hematol Oncol. 2020 Nov;42(8):e756-e758. doi: 10.1097/MPH.0000000000001647. J Pediatr Hematol Oncol. 2020. PMID: 31743316
The REVAMP trial: key questions remain.
Sato T, Yanagisawa R. Sato T, et al. Among authors: yanagisawa r. Lancet. 2024 Jan 6;403(10421):28-29. doi: 10.1016/S0140-6736(23)01919-0. Lancet. 2024. PMID: 38184334 No abstract available.
Concerns about the ALIFE2 trial.
Yanagisawa R, Fujiwara SI, Sato T. Yanagisawa R, et al. Lancet. 2024 Jan 20;403(10423):246-247. doi: 10.1016/S0140-6736(23)02339-5. Lancet. 2024. PMID: 38245242 No abstract available.
Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors.
Yanagisawa R, Hirakawa T, Doki N, Ikegame K, Matsuoka KI, Fukuda T, Nakamae H, Ota S, Hiramoto N, Ishikawa J, Ara T, Tanaka M, Koga Y, Kawakita T, Maruyama Y, Kanda Y, Hino M, Atsuta Y, Yabe H, Tsukada N. Yanagisawa R, et al. Int J Hematol. 2023 Mar;117(3):421-427. doi: 10.1007/s12185-022-03489-4. Epub 2022 Nov 20. Int J Hematol. 2023. PMID: 36403180
Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients.
Tamaki M, Akahoshi Y, Okada Y, Uchida N, Tanaka M, Doki N, Sawa M, Maruyama Y, Ueda Y, Miyakoshi S, Katayama Y, Kawakita T, Kimura T, Onizuka M, Fukuda T, Atsuta Y, Yanagisawa R, Yakushijin K, Kanda J, Nakasone H. Tamaki M, et al. Among authors: yanagisawa r. Cytotherapy. 2023 Nov;25(11):1220-1228. doi: 10.1016/j.jcyt.2023.06.002. Epub 2023 Jun 20. Cytotherapy. 2023. PMID: 37341665
Quantitative assessment of PTPN11 or RAS mutations at the neonatal period and during the clinical course in patients with juvenile myelomonocytic leukaemia.
Matsuda K, Sakashita K, Taira C, Tanaka-Yanagisawa M, Yanagisawa R, Shiohara M, Kanegane H, Hasegawa D, Kawasaki K, Endo M, Yajima S, Sasaki S, Kato K, Koike K, Kikuchi A, Ogawa A, Watanabe A, Sotomatsu M, Nonoyama S, Koike K. Matsuda K, et al. Among authors: yanagisawa r. Br J Haematol. 2010 Feb;148(4):593-9. doi: 10.1111/j.1365-2141.2009.07968.x. Epub 2009 Oct 29. Br J Haematol. 2010. PMID: 19874312 Free article.
393 results